HomeCompareQLGN vs STAG

QLGN vs STAG: Dividend Comparison 2026

QLGN yields 62.31% · STAG yields 3.44%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 QLGN wins by $710.7K in total portfolio value
10 years
QLGN
QLGN
● Live price
62.31%
Share price
$3.21
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$729.0K
Annual income
$175,361.30
Full QLGN calculator →
STAG
STAG Industrial Inc.
● Live price
3.44%
Share price
$36.09
Annual div
$1.24
5Y div CAGR
0.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$18.3K
Annual income
$462.22
Full STAG calculator →

Portfolio growth — QLGN vs STAG

📍 QLGN pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodQLGNSTAG
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, QLGN + STAG cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
QLGN pays
STAG pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

QLGN
Annual income on $10K today (after 15% tax)
$5,295.95/yr
After 10yr DRIP, annual income (after tax)
$149,057.10/yr
STAG
Annual income on $10K today (after 15% tax)
$292.45/yr
After 10yr DRIP, annual income (after tax)
$392.89/yr
At 15% tax rate, QLGN beats the other by $148,664.22/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of QLGN + STAG for your $10,000?

QLGN: 50%STAG: 50%
100% STAG50/50100% QLGN
Portfolio after 10yr
$373.7K
Annual income
$87,911.76/yr
Blended yield
23.53%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on STAG right now

QLGN
No analyst data
Altman Z
-5.6
Piotroski
3/9
STAG
Analyst Ratings
9
Buy
9
Hold
3
Sell
Consensus: Buy
Price Target
$45.00
+24.7% upside vs current
Range: $39.00 — $59.00
Altman Z
1.2
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

QLGN buys
0
STAG buys
0
No recent congressional trades found for QLGN or STAG in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricQLGNSTAG
Forward yield62.31%3.44%
Annual dividend / share$2.00$1.24
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0.3%
Portfolio after 10y$729.0K$18.3K
Annual income after 10y$175,361.30$462.22
Total dividends collected$608.8K$4.0K
Payment frequencyquarterlymonthly
SectorStockREIT

Year-by-year: QLGN vs STAG ($10,000, DRIP)

YearQLGN PortfolioQLGN Income/yrSTAG PortfolioSTAG Income/yrGap
1← crossover$16,931$6,230.53$10,665$345.09+$6.3KQLGN
2$27,974$9,858.52$11,364$357.70+$16.6KQLGN
3$45,156$15,223.51$12,098$370.43+$33.1KQLGN
4$71,283$22,966.14$12,869$383.28+$58.4KQLGN
5$110,155$33,882.50$13,677$396.23+$96.5KQLGN
6$166,800$48,934.07$14,524$409.27+$152.3KQLGN
7$247,726$69,249.85$15,411$422.41+$232.3KQLGN
8$361,186$96,119.21$16,339$435.61+$344.8KQLGN
9$517,443$130,974.20$17,311$448.89+$500.1KQLGN
10$729,026$175,361.30$18,327$462.22+$710.7KQLGN

QLGN vs STAG: Complete Analysis 2026

QLGNStock

Qualigen Therapeutics, Inc., a biotechnology company, develops novel therapeutic products for the treatment of cancer and infectious diseases. It offers FastPack, a rapid diagnostic testing system. The company is developing QN-302 for the treatment of pancreatic ductal adenocarcinoma; QN-247, a DNA coated gold nanoparticle cancer drug candidate that targets various cancers; RAS-F, a small-molecule RAS oncogene protein-protein inhibitor that blocks RAS mutations and inhibits tumor formation; and STARS blood cleansing system, a DNA/RNA-based treatment device that removes tumor-produced compounds and viruses from a patient's blood. Qualigen Therapeutics, Inc. was founded in 1996 and is based in Carlsbad, California.

Full QLGN Calculator →

STAGREIT

STAG Industrial, Inc. (NYSE: STAG) is a real estate investment trust focused on the acquisition and operation of single-tenant, industrial properties throughout the United States. By targeting this type of property, STAG has developed an investment strategy that helps investors find a powerful balance of income plus growth.

Full STAG Calculator →
📬

Get this QLGN vs STAG comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

QLGN vs SCHDQLGN vs JEPIQLGN vs OQLGN vs KOQLGN vs MAINQLGN vs PLDQLGN vs EQRQLGN vs VICI

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.